Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Abemaciclib in Patients With Oligodendroglioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03969706
Recruitment Status : Recruiting
First Posted : May 31, 2019
Last Update Posted : May 25, 2022
Abramson Cancer Center of the University of Pennsylvania
University of Pennsylvania
Information provided by (Responsible Party):
Stephen Bagley, MD, MSCE, Abramson Cancer Center of the University of Pennsylvania

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 15, 2025
Estimated Study Completion Date : May 15, 2027